Premium
Characterizing the original anti‐C5 function‐blocking antibody, BB5.1, for species specificity, mode of action and interactions with C5
Author(s) -
Zelek Wioleta M.,
Menzies Georgina E.,
Brancale Andrea,
Stockinger Brigitta,
Morgan Bryan Paul
Publication year - 2020
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1111/imm.13228
Subject(s) - anaphylatoxin , monoclonal antibody , complement system , eculizumab , complement component 5 , antibody , complementarity determining region , biology , blocking antibody , computational biology , microbiology and biotechnology , immunology
The work provides a mechanistic basis for the activities of this landmark antibody BB5.1, a much‐used tool that was a major impetus to the development of anti‐complement drugs for human disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom